A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
Author(s) -
Ventura Simonovich,
Leandro Daniel Burgos Pratx,
Paula Scibona,
Maria Valeria Beruto,
Marcelo Vallone,
Carolina Vázquez,
Nadia Savoy,
Diego Giunta,
Lucía Gómez Pérez,
Marisa del Lujan Sanchez,
Andrea V. Gamarnik,
Diego Ojeda,
Diego Mario Santoro,
Pablo J Camino,
Sebastian Antelo,
Karina Rainero,
Gabriela Vidiella,
Erica A. Miyazaki,
Wanda Cornistein,
Omar A Trabadelo,
Fernando M Ross,
Mariano Spotti,
Gabriel Funtowicz,
Walter Scordo,
Marcelo Losso,
Inés Ferniot,
Pablo E Pardo,
Eulalia Rodríguez,
Pablo Rucci,
Julieta Pasquali,
Nora Fuentes,
Mariano Esperatti,
Gerardo A Speroni,
Esteban C. Nannini,
Alejandra Matteaccio,
Hernán Michelángelo,
Dean Follmann,
H. Clifford Lane,
Waldo Belloso
Publication year - 2020
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2031304
Subject(s) - convalescent plasma , covid-19 , pneumonia , medicine , randomized controlled trial , virology , intensive care medicine , outbreak , disease , infectious disease (medical specialty)
Convalescent plasma is frequently administered to patients with Covid-19 and has been reported, largely on the basis of observational data, to improve clinical outcomes. Minimal data are available from adequately powered randomized, controlled trials.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom